Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

Alzchem share plunges after quarterly results, forecasts likely to be cut

The Alzchem share fell temporarily by double digits to its lowest level since early February and was still down 8.8 percent in the afternoon at €147.40. The stock thus broke out of its sideways movement since the summer. Alzchem confirmed its forecast for 2026, but Berenberg analyst Gerhard Orgonas expects that market estimates for operating profit will have to be revised down by around four to five percent due to accelerated write‑downs on a new nitroguanidine plant. » More on finanzen.net
Alzchem: quarterly profit shrinks despite slight revenue increase

In the third quarter Alzchem’s revenue rose slightly to almost €140.0 million (previous year approx. €137.0 million), while EBITDA fell from €29.7 million to €28.7 million and the margin declined by 1.2 percentage points to 20.5%. Profit decreased from €16.3 million to €13.5 million. The company confirmed its full-year guidance of around €600 million in revenue and about €126 million in EBITDA. In the first nine months, revenues increased 4% to €443.8 million and EBITDA rose 8% to €93.2 million; results were weighed down by higher energy and raw material costs as well as start-up expenses for new capacities. » More on finanzen.net
Alzchem Group approves share buyback of up to €20 million

The management board of Alzchem Group, with the supervisory board’s approval, has decided to repurchase up to 125,000 shares over a period of up to 12 months with a total volume of up to €20 million. The shares may be used as acquisition currency, for employee participation programmes, or for cancellation and capital reduction. The buyback will start after the publication of the Q3 figures on 29 October 2026 and after the expiry of the closed period; exact details will be announced before the start. » More on finanzen.net

Historical dividends Dividends

All dividend metrics All metrics

In 2024, AlzChem has already paid €1.30 in dividends. The last payout was in May 2024.

Financials

In the last quarter, AlzChem had revenue of €139.88m and net profit of €13.5m

(EUR)	September 2026	YoY
Revenue	139.88m	1.91%
Gross profit	92.52m	109.23%
Net profit	13.5m	17.12%
EBITDA	29.63m	3.00%

Fundamentals

Metric	Value
Market capitalization	€1.62bn
Number of shares	10.12m
52-week high/low	€210.60 - €123.20
Dividends	No
Beta	0.55
P/E ratio	-
PEG ratio	-
P/B ratio	-
P/S ratio	-

Company profile

AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand. It also provides fine and specialty chemicals, including products based on calcium carbide, calcium cyanamide, hydrogen cyanamide, dicyandiamide, guanidine, guanamines, and nitroguanidine, as well as aromatic and aliphatic nitriles; calcium cyanamide under the PERLKA name; germicide for use in pig pens under the ALZOGUR name; plant growth regulators under the Dormex and Sitofex name; and plant protection additives under the BREAK-THRU name. In addition, the company offers products for use in hot metal desulfurization and secondary metallurgy applications; and technical gases. Further, it provides chemical park operations and administrative services, as well as produces and distributes various infrastructure services. AlzChem Group AG was founded in 1908 and is based in Trostberg, Germany.